Equity Profile

CTEV

Claritev Corporation

Health CareHealth Care Technology$715.5M

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Claritev Corporation is a healthcare technology company focused on developing innovative solutions to improve patient care and streamline healthcare processes. With a market cap of $1 billion, it operates in a sector that is increasingly leveraging technology to enhance efficiency and outcomes in healthcare delivery.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$1.58

Revenue

Revenue growth is crucial for assessing the company's ability to expand its market presence and sustain operations.

$250M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing estimates by 15.75%. The stock reacted negatively, dropping 8.54% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Claritev to report an EPS of $1.58 and revenue of $250 million for Q2-2026, indicating a cautious outlook after recent losses.

Bull Case

If Claritev can meet or exceed EPS and revenue expectations, it may signal a turnaround in performance, boosting investor confidence.

Bear Case

Continued losses or failure to meet expectations could further erode investor trust and lead to a significant drop in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.58

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$250M

Revenue growth is crucial for assessing the company's ability to expand its market presence and sustain operations.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Claritev achieve a positive EPS this quarter?

Given the company's recent history of losses, a positive EPS could signal a significant turnaround and restore investor confidence.

What are the revenue growth projections for the upcoming quarters?

Understanding future revenue growth is critical for assessing the company's long-term viability and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for a turnaround in Claritev's performance, given the recent focus on healthcare technology innovation.

Supporting Evidence

The stock has shown volatility in response to earnings surprises, indicating that investor sentiment can shift quickly.

Options pricing suggests a significant move, which may reflect underlying expectations not captured in consensus estimates.

Key Risk

If EPS comes in significantly better than expected, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal for Claritev, as it seeks to demonstrate recovery from previous losses and regain investor trust.

Bull Confirmed If

Achieving an EPS of $1.58 or better would confirm the bull case and indicate a recovery in profitability.

Bear Confirmed If

An EPS worse than -$4.41 would confirm the bear case, suggesting ongoing operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a substantial move, suggesting that investors expect significant volatility around the earnings report.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Claritev beats expectations, history suggests the stock could rise significantly, potentially around +6.82% based on past performance.

In-Line / Cautious

If the results are in line but management expresses caution, the stock may experience a muted reaction, reflecting ongoing uncertainty.

Miss

If the company misses expectations, the stock could drop, with historical data suggesting a potential decline of around +6.82%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or technology advancements.
2Management's commentary on cost management and operational efficiency.
3Insights into customer acquisition and retention strategies.
4Future revenue guidance and market expansion plans.
5Responses to analyst questions about competitive pressures in the healthcare technology space.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$1.58

Revenue

Revenue growth is crucial for assessing the company's ability to expand its market presence and sustain operations.

$250M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CTEV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 5Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-51.72%

Avg Stock Reaction

+6.82%

Last Quarter Recap

In Q1-2026, Claritev reported an EPS of -$4.41, missing estimates by 15.75%. The stock reacted negatively, dropping 8.54% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Claritev to report an EPS of $1.58 and revenue of $250 million for Q2-2026, indicating a cautious outlook after recent losses.

Bull Case

If Claritev can meet or exceed EPS and revenue expectations, it may signal a turnaround in performance, boosting investor confidence.

Bear Case

Continued losses or failure to meet expectations could further erode investor trust and lead to a significant drop in stock price.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.58

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$250M

Revenue growth is crucial for assessing the company's ability to expand its market presence and sustain operations.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Claritev achieve a positive EPS this quarter?

Given the company's recent history of losses, a positive EPS could signal a significant turnaround and restore investor confidence.

What are the revenue growth projections for the upcoming quarters?

Understanding future revenue growth is critical for assessing the company's long-term viability and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for a turnaround in Claritev's performance, given the recent focus on healthcare technology innovation.

Supporting Evidence

The stock has shown volatility in response to earnings surprises, indicating that investor sentiment can shift quickly.

Options pricing suggests a significant move, which may reflect underlying expectations not captured in consensus estimates.

Key Risk

If EPS comes in significantly better than expected, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal for Claritev, as it seeks to demonstrate recovery from previous losses and regain investor trust.

Bull Confirmed If

Achieving an EPS of $1.58 or better would confirm the bull case and indicate a recovery in profitability.

Bear Confirmed If

An EPS worse than -$4.41 would confirm the bear case, suggesting ongoing operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±57.32%

Historical Avg

±10.3%

Pricing rich

The options market is pricing in a substantial move, suggesting that investors expect significant volatility around the earnings report.

Options are pricing ±57.3% while CTEV has averaged ±10.3% over the last 5 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

210.8%

Calls (4K)P/C Ratio: 0.43Puts (29K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Claritev beats expectations, history suggests the stock could rise significantly, potentially around +6.82% based on past performance.

In-Line / Cautious

If the results are in line but management expresses caution, the stock may experience a muted reaction, reflecting ongoing uncertainty.

Miss

If the company misses expectations, the stock could drop, with historical data suggesting a potential decline of around +6.82%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or technology advancements.
2Management's commentary on cost management and operational efficiency.
3Insights into customer acquisition and retention strategies.
4Future revenue guidance and market expansion plans.
5Responses to analyst questions about competitive pressures in the healthcare technology space.